At Fortune Infosys, we are a team of qualified and experienced professionals who develop scalable, efficient, and customized software for the pharmaceutical industry. We develop US FDA 21 CFR Part 11 compliant custom software for clientele from the pharmaceutical sector. Over the years, we have helped our clients achieve exceptional results through excellent inventory management, workflow management, enhanced customer service, and enabled them to leverage technology to make informed decisions and projections.
At Fortune Infosys, we provide pharmaceutical software to companies required to comply with FDA 21 CFR Part 11, Electronic Records; Electronic Signatures. Part 11 aims to protect the electronic data within your systems. Accordingly, our software and solutions help such companies ensure compliance with every aspect of 21 CFR Part 11. Additionally, we offer training courses on all the elements of FDA regulations, requirements, documents, and validation practices to help you ensure the highest levels of compliance.
Outsourcing custom pharmaceutical software application development to an experienced partner like Fortune Infosys has its unique, sustainable benefits. One of the most significant is developing pharmaceutical software compliant with HIPAA and FDA 21 CFR Part 11. Yes. While developing customized applications to serve the distinct needs of our clients across the pharmaceutical sector, we ensure the software FDA 21 CFR Part 11 and HIPAA compliant. Additionally, our highly experienced developers understand the needs of our clients and incorporate technologies, capabilities, and functionalities that business value for them. Besides, timely project completions and comprehensive technical support make us the best custom software application development company for the pharmaceutical sector.
HIPAA stands for Health Insurance Portability and Accountability Act. Pharmaceutical software compliant with HIPAA ensures enhanced data protection, expedites stakeholder communication, accelerates internal processes, helps companies adhere to the legalities concerning pharmaceutical processes, secures user authentication, etc., and thus ensures business excellence across every department.
A software compliant with US FDA 21 CFR Part 11 ensures compliance with the regulations concerning electronic documentation and electronic signatures. Accordingly, we develop a custom software application for the pharmaceutical industry compliant with US FDA 21 CFR Part 11. So, companies do not have to worry about the additional compliance requirement put forth by 21 CFR Part 11. Choosing us to develop a custom software compliant with its needs serves the purpose.